Ticker
KRROCompany Name
KORRO BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 180.43M | $ 33.61M | 18.63% |
3/31/2025 | $ 202.21M | $ 64.14M | 31.72% |
12/31/2024 | $ 226.24M | $ 55.64M | 24.59% |
9/30/2024 | $ 243.54M | $ 64.97M | 26.68% |
6/30/2024 | $ 249.59M | $ 92.92M | 37.23% |
3/31/2024 | $ 197.99M | $ 142.35M | 71.9% |
12/31/2023 | $ 221.66M | $ 169.71M | 76.56% |
9/30/2023 | $ 46.35M | $ 43.69M | 94.26% |
6/30/2023 | $ 79.38M | $ 41.67M | 52.49% |
3/31/2023 | $ 101.5M | $ 42.55M | 41.92% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for KORRO BIO INC is calculated as follows: CashnEq [ $ 226.05M ] / Assets [ $ 234.32M ]
(=) Cash to Assets [ 96.47% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.76% |
average | 9.78% |
median | 6.42% |
std | 9.53% |